Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/16/2009 | US7547686 Combretastatin A-3 prodrug |
06/16/2009 | US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones |
06/16/2009 | US7547444 Methods for controlling fungi and bacteria |
06/16/2009 | US7547274 Radioactive member and method of making |
06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
06/11/2009 | WO2009071504A1 2,6-disubstituted pyridines as soluble guanylate cyclase activators |
06/11/2009 | WO2009071449A1 Pyridylmethyl-sulfonamide compounds |
06/11/2009 | WO2009071448A1 Pyridylmethyl-sulfonamide compounds |
06/11/2009 | WO2009070910A2 Carboxamide derivatieves having cooling properties |
06/11/2009 | WO2009055629A3 Cyclohexeneamide derivatives and their use as trpv1 antagonist |
06/11/2009 | WO2009054742A3 Novel precursors |
06/11/2009 | WO2009050366A3 Arylamine synthesis method |
06/11/2009 | WO2009027811A3 Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same |
06/11/2009 | WO2008110278A3 Use of n2-phenylamidines as herbicides and herbicidal agents comprising the same |
06/11/2009 | WO2002030358A3 Modulation of ccr4 function |
06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
06/11/2009 | US20090149510 Compositions and methods for modulating a kinase cascade |
06/11/2009 | US20090149508 Process for the preparation of substituted phenyl ether compounds |
06/11/2009 | US20090149503 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
06/11/2009 | US20090149468 Substituted heterocyclic compounds and methods of use |
06/11/2009 | US20090149460 New Compounds |
06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
06/11/2009 | US20090149444 Benzylamine analogues |
06/11/2009 | US20090149439 Pyridylmethysulfone derivative |
06/11/2009 | US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
06/11/2009 | US20090145757 Redox Polymers |
06/11/2009 | CA2705489A1 Pyridylmethyl-sulfonamide compounds |
06/10/2009 | EP2066637A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
06/10/2009 | EP2066636A1 5-phenyl-nicotinamide derivatives |
06/10/2009 | EP2066635A2 2-phenoxy nicotine acid derivative and use thereof |
06/10/2009 | EP2066634A1 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators |
06/10/2009 | EP2066633A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
06/10/2009 | EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
06/10/2009 | EP2066631A1 Pyridine borane complexes |
06/10/2009 | EP2066620A1 Di-aromatic substituted amides as inhibitors for glyt1 |
06/10/2009 | EP2066615A2 Cyclopentane derivatives as antiglaucoma agents |
06/10/2009 | EP1844001B1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
06/10/2009 | EP1805142A4 Novel pyridine compounds, process for their preparation and compositions containing them |
06/10/2009 | EP0975710B2 Polymer electroluminescent device |
06/10/2009 | CN101454287A Substituted cyanopyridines as protein kinase inhibitors |
06/10/2009 | CN101454286A Method for producing phenoxypyridine derivative |
06/10/2009 | CN101454285A Oxadiazole derivatives as comt inhibitors |
06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
06/10/2009 | CN101450926A Metal zinc ammonchelidonic acid complexes and preparation method thereof |
06/10/2009 | CN101450925A Photosensitive 4'-(4-diazo) phenyl (2,2':6',2'')-terpyridyl fluoroborate, preparation method thereof and decoration to sheet substrate surface |
06/10/2009 | CN100497358C Iridium compound and organic electroluminescent device using the same |
06/10/2009 | CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
06/10/2009 | CN100497322C Method for producing substituted phenylsulfonyl urea |
06/10/2009 | CN100497311C Preparation method of 2-amido-3-5-trifluoro picoline |
06/10/2009 | CN100497310C Preparation method of 2-chlorin-5-trifluoro picoline |
06/10/2009 | CN100497309C Method for synthesizing heteroaryl thiosemicarbazone antineoplastic |
06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
06/09/2009 | US7544807 Ionic liquids |
06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
06/09/2009 | US7544312 Charge transport compositions and electronic devices made with such compositions |
06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
06/09/2009 | CA2296727C Pyrazine derivatives, preparation and medicines containing them |
06/09/2009 | CA2251331C Calcilytic compounds |
06/04/2009 | WO2009070515A2 Synthesis of diaminodinitropyridine and diaminodinitrobenzene |
06/04/2009 | WO2009070130A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof |
06/04/2009 | WO2009068885A1 Dinuclear, quadruply-stranded compounds comprising palladium or platinum |
06/04/2009 | WO2009068652A1 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines as soluble guanylate cyclase activators |
06/04/2009 | WO2009068623A1 Crystalline form of an antimalarial compound |
06/04/2009 | WO2009068468A2 Pyridine compounds |
06/04/2009 | WO2009067797A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
06/04/2009 | WO2008024415A8 Process for the synthesis of cmhtp and intermediates thereof |
06/04/2009 | WO2007132478A3 Process for the preparation of pure risedronic acid or salts |
06/04/2009 | US20090143595 Use of grinding in chemical synthesis |
06/04/2009 | US20090143594 Process for the catalytic synthesis of diaryl ethers |
06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
06/04/2009 | US20090143583 Transfection reagents |
06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
06/04/2009 | US20090143445 HDAC Inhibitors |
06/04/2009 | US20090143430 Erythropoietin production accelerator |
06/04/2009 | US20090143409 3-pyridinecarboxamide derivatives as hdl-cholesterol raising agents |
06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
06/04/2009 | US20090143386 Human adam-10 inhibitors |
06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
06/04/2009 | US20090142554 Yellow Azo Dyes for Ink Jet Printing |
06/04/2009 | CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
06/04/2009 | CA2706576A1 Pyridine compounds |
06/03/2009 | EP2065380A1 Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer |
06/03/2009 | EP2065371A1 Chiral organic catalysts for the stereoselective reduction of carbon-nitrogen double bonds for the preparation of enantiomerically enriched amines |
06/03/2009 | EP2065370A1 2-cyanobenzene sulfonamides as pesticides |
06/03/2009 | EP2065369A1 Urea compound or salt thereof |
06/03/2009 | EP2065365A2 Functional monomers for molecular recognition and catalysis |
06/03/2009 | EP2065357A1 Improved process for the catalytic synthesis of diaryl ethers |
06/03/2009 | EP2064199A1 Diaryl ether derivatives and uses thereof |
06/03/2009 | EP2064184A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
06/03/2009 | EP2064183A2 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
06/03/2009 | EP2064177A2 Protease inhibitors |
06/03/2009 | EP2063985A2 Ionic additive for catalysis in biphasic reaction systems |
06/03/2009 | EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors |
06/03/2009 | CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone |
06/03/2009 | CN101445481A Forcipate thioacid amide ligand, complex compound and application of sulfo-2, 6-pyridine diformamide framework |
06/03/2009 | CN101445480A Bifunctional organic ligand 2, 4, 6-pyridine tricarboxylic acid, water-soluble rare-earth fluorescence labeling material and preparation method thereof |
06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |